{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:01:48Z","timestamp":1769756508077,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015377","name":"Nihon Medi-Physics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12149-025-02020-z","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T09:06:42Z","timestamp":1739524002000},"page":"466-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras"],"prefix":"10.1007","volume":"39","author":[{"given":"Akiko","family":"Oya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurina","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-827X","authenticated-orcid":false,"given":"Atsutaka","family":"Okizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"Suppl 4","key":"2020_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","volume":"9","author":"RE Coleman","year":"2004","unstructured":"Coleman RE. Bisphosphonates: clinical experience. Oncologist. 2004;9(Suppl 4):14\u201327.","journal-title":"Oncologist"},{"key":"2020_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","volume":"27","author":"MB Karen","year":"2008","unstructured":"Karen MB, Carol VG, Andrea MM. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev. 2008;27:41\u201355.","journal-title":"Cancer Metastasis Rev"},{"key":"2020_CR3","first-page":"1","volume":"16","author":"H Shibata","year":"2016","unstructured":"Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, et al. Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. ESMO Open. 2016;16:1.","journal-title":"ESMO Open"},{"key":"2020_CR4","first-page":"143","volume":"1","author":"M Lorenzo","year":"2004","unstructured":"Lorenzo M, Luigia F, Luca P, Ivana B, Isabel R. Current role of bone scan with phosphonates in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging. 2004;1:143\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2967\/jnumed.119.234260","volume":"61","author":"GJR Cook","year":"2020","unstructured":"Cook GJR, Goh V. Molecular imaging of bone metastases and their response to therapy. J Nucl Med. 2020;61:799\u2013806.","journal-title":"J Nucl Med"},{"key":"2020_CR6","first-page":"14N","volume":"58","author":"KJ Donohoe","year":"2017","unstructured":"Donohoe KJ, Cohen EJ, Giammarile F, Grady E, Greenspan BS, Henkin RE, et al. Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts. J Nucl Med. 2017;58:14N-17N.","journal-title":"J Nucl Med"},{"key":"2020_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<28::AID-PROS3>3.0.CO;2-M","volume":"38","author":"S Akimoto","year":"1999","unstructured":"Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H. Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) grade. Prostate. 1999;38:28\u201334.","journal-title":"Prostate"},{"key":"2020_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y","volume":"61","author":"MS Soloway","year":"1988","unstructured":"Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195\u2013202.","journal-title":"Cancer"},{"key":"2020_CR9","first-page":"1401","volume":"38","author":"YE Erdi","year":"1997","unstructured":"Erdi YE, Humm JL, Imbriaco M, Yeung H, Larson SM. Quantitative bone metastases analysis based on image segmentation. J Nucl Med. 1997;38:1401\u20136.","journal-title":"J Nucl Med"},{"key":"2020_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/JCO.2011.36.5791","volume":"30","author":"RD Elizabeth","year":"2012","unstructured":"Elizabeth RD, Xiaoyu J, Irina SM, Ryan DS, Heiko S, Josef JF, et al. Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol. 2012;30:519\u201324.","journal-title":"J Clin Oncol"},{"key":"2020_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.euf.2016.01.005","volume":"2","author":"R Mariana","year":"2016","unstructured":"Mariana R, Robert J, John A, Christophe M, Leena M, Mika M, et al. Bone scan index and progression-free survival data for progressive metastatic castration-resistant prostate cancer patients who received ODM-201 in the ARADES Multicentre Study. Eur Urol Focus. 2016;2:547\u201352.","journal-title":"Eur Urol Focus"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/2191-219X-3-64","volume":"3","author":"K Reza","year":"2013","unstructured":"Reza K, Peter G, H\u00e5kan L, Milan L, Mattias O, Karl S, et al. Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index. EJNMMI Res. 2013;3:64.","journal-title":"EJNMMI Res"},{"key":"2020_CR13","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024. https:\/\/uroweb.org\/guidelines\/prostate-cancer\/. Accessed 14 Sept 2024."},{"key":"2020_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jamaoncol.2018.1093","volume":"4","author":"AJ Armstrong","year":"2018","unstructured":"Armstrong AJ, Anand A, Edenbrandt L, Bondesson E, Bjartell A, Widmark A, et al. Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:944\u201351.","journal-title":"JAMA Oncol"},{"key":"2020_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2478\/raon-2019-0058","volume":"54","author":"V Frantellizzi","year":"2019","unstructured":"Frantellizzi V, Pani A, Ippoliti MD, Farcomeni A, Aloise I, Colosi M, et al. Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment. Radiol Oncol. 2019;54:40\u20137.","journal-title":"Radiol Oncol"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2012.01.037","volume":"62","author":"D Ulmert","year":"2012","unstructured":"Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, et al. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. Eur Urol. 2012;62:78\u201384.","journal-title":"Eur Urol"},{"key":"2020_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s12149-020-01524-0","volume":"34","author":"Y Aoki","year":"2020","unstructured":"Aoki Y, Nakayama M, Nomura K, Tomita Y, Nakajima K, Yamashina M, et al. The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer. Ann Nucl Med. 2020;34:926\u201331.","journal-title":"Ann Nucl Med"},{"key":"2020_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12149-014-0921-y","volume":"29","author":"M Koizumi","year":"2015","unstructured":"Koizumi M, Wagatsuma K, Miyaji N, Murata T, Miwa K, Takiguchi T, et al. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting. Ann Nucl Med. 2015;29:138\u201348.","journal-title":"Ann Nucl Med"},{"key":"2020_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s12149-022-01763-3","volume":"36","author":"K Motegi","year":"2022","unstructured":"Motegi K, Miyaji N, Yamashita K, Koizumi M, Terauchi T. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients. Ann Nucl Med. 2022;36:834\u201341.","journal-title":"Ann Nucl Med"},{"key":"2020_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12149-014-0819-8","volume":"28","author":"O Tokuda","year":"2014","unstructured":"Tokuda O, Harada Y, Ohishi Y, Matsunaga N, Edenbrandt L. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients. Ann Nucl Med. 2014;28:329\u201339.","journal-title":"Ann Nucl Med"},{"key":"2020_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12149-016-1132-5","volume":"31","author":"M Urano","year":"2017","unstructured":"Urano M, Maki Y, Nishikawa H, Kawai T, Shiraki N, Shibamoto Y. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients. Ann Nucl Med. 2017;31:40\u20135.","journal-title":"Ann Nucl Med"},{"key":"2020_CR22","unstructured":"Nihon Medi-Physics Co., Ltd. VSBONE BSI Ver.3.0 Handbook. https:\/\/www.nmp.co.jp\/member\/bone\/bsi3\/index.html\/. Accessed 22 Aug 2024."},{"key":"2020_CR23","first-page":"3","volume":"46","author":"DG Darambara","year":"2002","unstructured":"Darambara DG, Todd-Pokropek A. Solid state detectors in nuclear medicine. Q J Nucl Med. 2002;46:3\u20137.","journal-title":"Q J Nucl Med"},{"key":"2020_CR24","first-page":"549","volume":"39","author":"H Otake","year":"2002","unstructured":"Otake H, Higuchi T, Takeuchi Y, Ryuo H, Jimbo M, Matsubara K, et al. Evaluation of efficiency of a semiconductor gamma camera. Kaku Igaku. 2002;39:549\u201353.","journal-title":"Kaku Igaku"},{"key":"2020_CR25","first-page":"2323","volume":"4","author":"L Verger","year":"2004","unstructured":"Verger L, Drezet A, d\u2019Aillon EG, Mestais C, Monnet O, Mont\u00e9mont G, et al. New perspectives in gamma-ray imaging with CdZnTe\/CdTe. Conf Record on IEEE Nucl Sci Symp and Med imag. 2004;4:2323\u20139.","journal-title":"Conf Record on IEEE Nucl Sci Symp and Med imag"},{"key":"2020_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2191-219X-3-9","volume":"3","author":"R Kaboteh","year":"2013","unstructured":"Kaboteh R, Damber JE, Gjertsson P, H\u00f6glund P, Lomsky M, Ohlsson M, et al. Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy. EJNMMI Res. 2013;3:9.","journal-title":"EJNMMI Res"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02020-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02020-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:00:02Z","timestamp":1745323202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02020-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02020-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the remaining authors, none were declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}